# A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

> **NCT02570893** · PHASE3 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 366 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Adjuvant radiotherapy
- **RADIATION:** Adjuvant radiotherapy
- **DRUG:** Paclitaxel and carboplatin

## Key facts

- **NCT ID:** NCT02570893
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-10
- **Final completion:** 2020-10
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2015-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570893, "A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02570893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*